Question 1

Does BNP Paribas Financial Markets own XBI stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BNP Paribas Financial Markets holds 16,777,726 shares of XBI (State Street SPDR SP Biotech ETF), worth $2.7B.

Question 2

How many shares of XBI does BNP Paribas Financial Markets own?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets holds 16,777,726 shares of XBI (State Street SPDR SP Biotech ETF).

Question 3

What is BNP Paribas Financial Markets' XBI position worth?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets' XBI position is worth $2.7B.

Question 4

Is BNP Paribas Financial Markets buying or selling XBI?

Accepted Answer

In Q2 2026, BNP Paribas Financial Markets reduced its XBI position by 4,378,146 shares (-20.7%).

Question 5

When did BNP Paribas Financial Markets first buy XBI?

Accepted Answer

BNP Paribas Financial Markets already held XBI in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	16.8M	-20.7%	$2.7B	0.9%	$158.25	0
2026-Q1	Increased	21.2M	+27.5%	$2.7B	1.3%	$127.60	63
2025-Q4	Increased	16.6M	+178.1%	$2B	0.9%	$121.81	73
2025-Q3	Decreased	6M	-21.6%	$597.7M	0.3%	$99.77	0
2025-Q2	Decreased	7.6M	-24.7%	$631.1M	0.4%	$82.55	0
2025-Q1	Decreased	10.1M	-15.0%	$819.2M	0.5%	$80.72	0
2024-Q4	Increased	11.9M	+294.7%	$1.1B	0.6%	$89.64	73
2024-Q3	Decreased	3M	-43.0%	$297.5M	0.2%	$98.33	0

XBIShowing 8 of 31 quarters

XBI
Showing 8 of 31 quarters